U.S. Sells All Remaining Shares of General Motors
Teva Could Market Generic Lipitor by Month’s End, Calcalist Says
Teva Pharmaceutical Industries Ltd. (TEVA) could begin marketing a generic version of Lipitor by the end of the month through a partnership with India’s Ranbaxy Laboratories Ltd. (RBXY), Calcalist reported today, without saying how it obtained the information..
A message left on the answering machine of a Teva spokesman before office hours was not immediately answered.
Click here for web link
To contact the editor responsible for this story: Calev Ben-David at email@example.com